期刊
ANALYST
卷 146, 期 10, 页码 3378-3390出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/d0an02333g
关键词
-
资金
- OrbiSIMS project in the Life Sciences and Health programme of the National Measurement System of the UK Department of Business, Energy and Industrial Strategy
Controlled-release formulations in the form of micro- or nanoparticles are increasingly popular in the pharmaceutical industry. The use of a multimodal approach, including MALDI MS imaging and TOF-SIMS analysis, helps monitor the distribution of drug in the lung and increases understanding of drug delivery with controlled-release microparticles.
Controlled-release formulations, in the form of micro- or nanoparticles, are increasingly attractive to the pharmaceutical industry for drug delivery. For respiratory illnesses, controlled-release microparticle formulations provide an opportunity to deliver a higher percentage of an inhaled medicament dose to the lung, thus potentially reducing the therapeutic dose, frequency of dosing, and minimising side-effects. We describe the use of a multimodal approach consisting of MALDI MS imaging, 3D depth profiling TOF-SIMS analysis, and histopathology to monitor the distribution of drug and excipients in sections taken from excised rat lungs following an inhaled administration of drug-laden microparticles. Following a single dose, the administered drug was detected in the lung via both MALDI MS and TOF-SIMS over a range of time points. Both imaging techniques enabled the characterisation of the distribution and retention of drug particles and identified differences in the capabilities of both imaging modalities. Histochemical staining of consecutive sections was used to provide biological context to the findings and will also be discussed in this presentation. We demonstrate how this multimodal approach could be used to help increase our understanding of the use of controlled release microparticles.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据